About Enhancer
| Enhancer ID: | E_01_0831 |
| Species: | human |
| Position : | chr12:55964237-55966237   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Nonalcoholic fatty liver disease |
| Pubmed ID: | 33334026 |
| Enhancer experiment: | Tag accumulation, staining and high content imaging, real time PCR, dendrogram hierarchical clustering using Ward's method |
| Enhancer experiment description: | Non-alcoholic fatty liver disease (NAFLD) has a large impact on global health. At the onset of disease, NAFLD is characterized by hepatic steatosis defined by the accumulation of triglycerides stored as lipid droplets. |
About Target gene
| Target gene : | CDK2 |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | Non-alcoholic fatty liver disease (NAFLD) has a large impact on global health. At the onset of disease, NAFLD is characterized by hepatic steatosis defined by the accumulation of triglycerides stored as lipid droplets. |
About TF
| TF name : | -- |
| TF experiment: | TAG?????????????????? PCR??????????????? |
| TF experiment description: | Non-alcoholic fatty liver disease (NAFLD) has a large impact on global health. At the onset of disease, NAFLD is characterized by hepatic steatosis defined by the accumulation of triglycerides stored as lipid droplets. |
About Function
| Enhancer function : | Non-alcoholic fatty liver disease (NAFLD) has a large impact on global health. At the onset of disease, NAFLD is characterized by hepatic steatosis defined by the accumulation of triglycerides stored as lipid droplets. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
Non-alcoholic fatty liver disease (NAFLD) has a large impact on global health. At the onset of disease, NAFLD is characterized by hepatic steatosis defined by the accumulation of triglycerides stored as lipid droplets. |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene